According to a recent survey, the pharma industry spent an
estimated $1.25 billion for each new molecular entity (NME)
approved by the FDA in 2004. The figure represents the second
consecutive year in which this figure has declined...
Italian processing machinery company IMA Group has decided to
increase its investment in a Chinese joint venture to tap into a
growth market at a time when its established territories in the
West are showing lacklustre growth, reports...
Dutch chemicals group DSM reported better than expected second
quarter results today, as higher selling prices in its industrial
chemicals unit and lower fixed costs boosted margins, write
Dominique Patton and Phil Taylor.
Swiss chemicals firm and contract manufacturer Lonza fulfilled its
promise of stronger financial results in the first half of 2005,
with profits coming in at the lower end of the forecast range, but
still on target, reports Phil Taylor.
Japan's Kirin Brewery Co has bought Hematech of the US, acquiring
the latter's core technology for the production of bovine-derived
human polyclonal antibodies which could be useful in the
development of a range of human-use...
Microbia has entered into a research collaboration with A*STAR's
Bioprocessing Technology Institute (BTI) in Singapore to improve
the efficiency of pharmaceutical production from actinomycete
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported
second-quarter sales of €3.34 billion, up 6 per cent from the
comparable period in 2004, thanks to price increases that overcame
An improved new statistical method developed by genome researchers,
is set to streamline the computation required to identify the
potential locations in the genome, as well as linking more gene
expression traits to two loci.